Efficacy and safety of mometasone furoate administered once-daily in the evening in patients with persistent asthma dependent on inhaled corticosteroids

References

• Expert Panel Report 2: Guidelines for the Diagnosis and Management of Asthma. Bethesda (MD): National Institutes of Health (National Heart, Lung, and Blood Institute); 1997. NIH Pub. No. 97–4051
   Google Scholar
• Global strategy for asthma management and prevention (GINA). NHLBI/WHO workshop report update. Bethesda (MD): National Institutes of Health (National Heart, Lung, and Blood Institute); 2002. NIH Pub. No. 02–3659
   Google Scholar
• British Guideline on the Management of Asthma. Thorax. 2003;58(Suppl I):i1–i79
   Google Scholar
• Anon. Expert panel report: guidelines for the diagnosis and management of asthma – update on selected topics 2002. J Allergy Clin Immunol 2002;110(Suppl):S141–S219
   Google Scholar
• Sly RM. Decreases in asthma mortality in the United States. Ann Allergy Asthma Immunol 2000;85:121–7
   PubMed Web of Science ®Google Scholar
• Suissa S, Ernst P. Inhaled corticosteroids: impact on asthma morbidity and mortality. J Allergy Clin Immunol 2001;107:937–44
   PubMed Web of Science ®Google Scholar
• Bender BG. Overcoming barriers to nonadherence in asthma treatment. J Allergy Clin Immunol 2002;109(Suppl):S554–559
   Google Scholar
• ZuWallack R, Adelglass J, Clifford DP, et al. Long-term efficacy and safety of fluticasone propionate powder administered once or twice daily via inhaler to patients with moderate asthma. Chest 2000;118:303–12
   PubMed Web of Science ®Google Scholar
• McFadden ER, Casale TB, Edwards TB, et al. Administration of budesonide once daily by means of turbuhaler to subjects with stable asthma. J Allergy Clin Immunol 1999;104:46–52
   PubMed Web of Science ®Google Scholar
• Noonan M, Karpel JP, Bensch GW, et al. Comparison of once-daily to twice-daily treatment with mometasone furoate dry powder inhaler. Ann Allergy Asthma Immunol 2001;86:36–43
   PubMed Web of Science ®Google Scholar
• Nayak AS, Banov C, Corren J, et al. Once-daily mometasone furoate dry powder inhaler in the treatment of patients with persistent asthma. Ann Allergy Asthma Immunol 2000;84:417–24
   PubMed Web of Science ®Google Scholar
• Nayak A, Lampl K, Segall N, Harrison J. Long term use of once-daily mometasone furoate is effective and well tolerated in patients with mild to moderate persistent asthma. J Allergy Clin Immunol 2001;107(Suppl):S98
   Google Scholar
• Kemp JP, Berkowitz RB, Miller SD, Murray JJ, Nolop K, Harrison JE. Mometasone furoate administered once daily is as effective as twice-daily administration for treatment of mild-to-moderate persistent asthma. J Allergy Clin Immunol 2000;106:485–92
   PubMed Web of Science ®Google Scholar
• American Thoracic Society. Standardization of spirometry, 1994 update. Am J Respir Crit Care Med 1995;152:1107–36
   PubMed Web of Science ®Google Scholar
• Crapo R. Reference values for lung function tests. Respir Care 1989;34:626–37
   Google Scholar
• Polgar G, Promadhat V. Pulmonary function testing in children: techniques and standards. Philadelphia: WB Saunders Co.; 1971
   Google Scholar
• Ware Jr JE, Sherbourne CD. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care 1992;30:473–83
   Google Scholar
• Marks GB, Dunn SM, Woolcock AJ. A scale for the measurement of quality of life in adults with asthma. J Clin Epidemiol 1992;45:461–72
   Google Scholar
• Toogood JH, Baskerville JC, Jennings B, Lefcoe NM, Johansson SA. Influence of dosing frequency and schedule on the response of chronic asthmatics to the aerosol steroid, budesonide. J Allergy Clin Immunol 1982;70:288–98
   Google Scholar
• Foresi A, Morelli MC, Catena E. Low-dose budesonide with the addition of an increased dose during exacerbations is effective in long-term asthma control [On behalf of the Italian Study Group]. Chest 2000;117:440–6
   Google Scholar
• Wasserman SI, Gross GN, Schoenwetter WF, et al. A 12-week dose-ranging study of fluticasone propionate powder in the treatment of asthma. J Asthma 1996;33(4):265–74
   PubMed Web of Science ®Google Scholar
• Banov CH, Howland 3rd WC, Lumry WR. Once-daily budesonide via Turbuhaler improves symptoms in adults with persistent asthma. Ann Allergy Asthma Immunol 2001;86:627–32
   PubMed Web of Science ®Google Scholar
• Joyce DP, Jackevicius C, Chapman KR, McIvor RA, Kesten S. The placebo effect in asthma drug therapy trials: a meta-analysis. J Asthma 2000;37:303–18
   Google Scholar
• Rand C. Patient and regimen-related factors that influence compliance with asthma therapy. Eur Respir Rev 1998;8:270–4
   Google Scholar
• Weiner P, Weiner M, Azgad Y. Long term clinical comparison of single versus twice daily administration of inhaled budesonide in moderate asthma. Thorax 1995;50:1270–3
   Google Scholar
• O’Connor B, Bonnaud G, Haahtela T, et al. Dose-ranging study of mometasone furoate dry powder inhaler in the treatment of moderate persistent asthma using fluticasone propionate as an active comparator. Ann Allergy Asthma Immunol 2001;86:397–404
   Google Scholar
• Wardlaw A, Larivee P, Eller J, Cockcroft DW, Ghaly L, Harris AG. Efficacy and safety of mometasone furoate dry powder inhaler vs fluticasone propionate metered-dose inhaler (MDI) in asthma subjects previously using fluticasone propionate. Ann Allergy Asthma Immunol 2004;93:49–55
   PubMed Web of Science ®Google Scholar
• Corren J, Berkowitz R, Murray J, Prenner B, Nolop K. Comparison of once-daily mometasone furoate versus once-daily budesonide in patients with moderate persistent asthma. Int J Clin Pract September 2003;57:567–72
   Google Scholar
• Bousquet J, D’Urzo A, Hebert J, et al. Comparison of the efficacy and safety of mometasone furoate dry powder inhaler to budesonide Turbuhaler. Eur Respir J 2000;16:808–16
   PubMed Web of Science ®Google Scholar
• Kemp J, Nayak A, Berkowitz R, et al. Rapid onset of action of mometasone furoate (MF) administered once daily by dry powder inhaler (DPI). Eur Respir J 2000;16(Suppl):338S
   Google Scholar
• Turner-Warwick M. Epidemiology of nocturnal asthma. Am J Med 1988;85:6–8
   PubMed Web of Science ®Google Scholar